540 related articles for article (PubMed ID: 32409147)
1. Immunometabolism during Mycobacterium tuberculosis Infection.
Howard NC; Khader SA
Trends Microbiol; 2020 Oct; 28(10):832-850. PubMed ID: 32409147
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.
Howard NC; Marin ND; Ahmed M; Rosa BA; Martin J; Bambouskova M; Sergushichev A; Loginicheva E; Kurepina N; Rangel-Moreno J; Chen L; Kreiswirth BN; Klein RS; Balada-Llasat JM; Torrelles JB; Amarasinghe GK; Mitreva M; Artyomov MN; Hsu FF; Mathema B; Khader SA
Nat Microbiol; 2018 Oct; 3(10):1099-1108. PubMed ID: 30224802
[TBL] [Abstract][Full Text] [Related]
3. Fidaxomicin has high
Sun Q; Wang S; Liao X; Jiang G; Huang H; Li H; Wang G
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33593474
[TBL] [Abstract][Full Text] [Related]
4. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
[TBL] [Abstract][Full Text] [Related]
7.
Bobba S; Howard NC; Das S; Ahmed M; Tang L; Thirunavukkarasu S; Larsen MH; Mathema B; Divangahi M; Khader SA
mBio; 2023 Oct; 14(5):e0094623. PubMed ID: 37682004
[TBL] [Abstract][Full Text] [Related]
8. Using a Heat Diffusion Model to Detect Potential Drug Resistance Genes of
Cui ZJ; Zhang WT; Zhu Q; Zhang QY; Zhang HY
Protein Pept Lett; 2020; 27(8):711-717. PubMed ID: 32167422
[TBL] [Abstract][Full Text] [Related]
9. Recent updates on drug resistance in Mycobacterium tuberculosis.
Singh R; Dwivedi SP; Gaharwar US; Meena R; Rajamani P; Prasad T
J Appl Microbiol; 2020 Jun; 128(6):1547-1567. PubMed ID: 31595643
[TBL] [Abstract][Full Text] [Related]
10. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis.
Tabriz NS; Skak K; Kassayeva LT; Omarkulov BK; Grigolashvili MA
Microb Drug Resist; 2020 Aug; 26(8):997-1004. PubMed ID: 32181685
[No Abstract] [Full Text] [Related]
12. Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens.
Chumpa N; Kawkitinarong K; Rotcheewaphan S; Sawatpanich A; Petsong S; Tumwasorn S; Suwanpimolkul G
Mol Biol Rep; 2020 Apr; 47(4):2501-2508. PubMed ID: 32124172
[TBL] [Abstract][Full Text] [Related]
13. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
mBio; 2018 May; 9(3):. PubMed ID: 29844114
[TBL] [Abstract][Full Text] [Related]
14. The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in
Kumwenda GP; Chipungu G; Sloan DJ; Kaimila Y; Chiumya K; Pangani H
Malawi Med J; 2018 Mar; 30(1):1-5. PubMed ID: 29868151
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
[TBL] [Abstract][Full Text] [Related]
16. GeneXpert
Christopher PM; ; Widysanto A
Int J Mycobacteriol; 2019; 8(4):351-358. PubMed ID: 31793505
[TBL] [Abstract][Full Text] [Related]
17. Novel mutation detection IN rpoB OF rifampicin-resistant Mycobacterium tuberculosis using pyrosequencing.
Htike Min PK; Pitaksajjakul P; Tipkrua N; Wongwit W; Jintaridh P; Ramasoota P
Southeast Asian J Trop Med Public Health; 2014 Jul; 45(4):843-52. PubMed ID: 25427352
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
Al-Mutairi NM; Ahmad S; Mokaddas EM
Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
[TBL] [Abstract][Full Text] [Related]
19. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
Melzer M; Gupta N; Petersen I; Cook S; Hall B
Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
[TBL] [Abstract][Full Text] [Related]
20. Genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran using MIRU-VNTR technique.
Khosravi AD; Shahraki AH; Dezfuli SK; Hashemzadeh M; Goodarzi H; Mohajeri P
Kaohsiung J Med Sci; 2017 Nov; 33(11):550-557. PubMed ID: 29050672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]